Alerts will be sent to your verified email
Verify EmailSUVENPHAR
Suven Pharma
|
Jubilant Pharmova
|
Syngene Internation.
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
17.0 . | 100.0 . | n/a |
Unclassified
|
|||
R&D as a % of Total Sales
|
1.57 % | 0.33 % | n/a |
Financials
|
|||
5 yr Average ROE
|
27.26 % | 8.35 % | 14.02 % |
5yr average Equity Multiplier
|
1.3 | 2.0 | 1.65 |
5yr Average Asset Turnover Ratio
|
0.61 | 0.59 | 0.51 |
5yr Avg Net Profit Margin
|
33.51 % | 7.13 % | 16.68 % |
Price to Book
|
15.5 | 2.48 | 6.39 |
P/E
|
109.79 | 23.47 | 60.2 |
5yr Avg Cash Conversion Cycle
|
70.98 Days | -19.21 Days | -1572.22 Days |
Inventory Days
|
76.62 Days | 81.78 Days | 17.83 Days |
Days Receivable
|
42.46 Days | 51.11 Days | 50.73 Days |
Days Payable
|
85.69 Days | 173.51 Days | -1569.1 Days |
5yr Average Interest Coverage Ratio
|
47.81 | 3.98 | 16.65 |
5yr Avg ROCE
|
32.61 % | 9.05 % | 14.42 % |
5yr Avg Operating Profit Margin
|
43.1 % | 18.69 % | 29.32 % |
5 yr average Debt to Equity
|
0.09 | 0.64 | 0.2 |
5yr CAGR Net Profit
|
-1.08 % | -38.8 % | 4.36 % |
5yr Average Return on Assets
|
20.57 % | 4.23 % | 8.45 % |
Shareholdings
|
|||
Promoter Holding
|
50.1 % | 50.68 % | 52.74 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-9.9 % | 0.0 | -17.67 % |
Change in Mutual Fund Holding (3 Yrs)
|
7.13 % | 3.61 % | 14.6 % |
Suven Pharma
|
Jubilant Pharmova
|
Syngene Internation.
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|